Clinical cost-cutting is bad medicine for quality healthcare
Health insurers' drive for cost-saving clinical services poses a threat to quality care, as highlighted by a recent Harvard study. Medibank has expanded its hospital ownership, raising concerns about the influence of private funders on patient care. Experts warn that such vertical integration may compromise the doctor-patient relationship and lead to disadvantaged healthcare outcomes.
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
Published 02 Jul 2026, 08:30 UTC · Updated 02 Jul 2026, 08:40 UTC
Summary by OZbrief Editorial. Original report: SMH. Editorial policy · Corrections
Trending
- 2026 Midwinter Ball: Political statements make an entrance
- ‘Witch-hunt’ in Niger as military regime rounds up LGBTQ+ population
- Aussie musicians vow to make voices heard in AI copyright war
- Football-free zone: Wimbledon extends World Cup screening ban to players’ lounge
- Iason Gabriel champions ethics in AI as Google DeepMind's first philosopher
- Aftershock frays nerves as many Venezuelans left to fend for themselves